Intuniv
These highlights do not include all the information needed to use INTUNIV safely and effectively. See full prescribing information for INTUNIV. INTUNIV (guanfacine) extended-release tablets, for oral useInitial U.S. Approval: 1986
b972af81-3a37-40be-9fe1-3ddf59852528
HUMAN PRESCRIPTION DRUG LABEL
Dec 23, 2022
Takeda Pharmaceuticals America, Inc.
DUNS: 039997266
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
guanfacine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
guanfacine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
guanfacine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
guanfacine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
guanfacine
Product Details
FDA regulatory identification and product classification information